dihydroergotamine has been researched along with Thrombocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Humphrey, PW; Keller, MP; Kikta, MJ; Silver, D | 1 |
| Comerota, AJ; White, JV | 1 |
2 other study(ies) available for dihydroergotamine and Thrombocytopenia
| Article | Year |
|---|---|
Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia | 1993 |
The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
Topics: Dihydroergotamine; Drug Therapy, Combination; Hemorrhage; Heparin; Hip Prosthesis; Humans; Knee Prosthesis; Postoperative Complications; Spasm; Thrombocytopenia; Thrombophlebitis; Vascular Diseases | 1986 |